Cortisol antiinflammatory effects are maximal at postoperative plasma concentrations

Critical Care Medicine

Volumn 33, Issue 7, 2005, Pages 1507-1512

  Yeager, Mark P ^a   Rassias, Athos J ^a   Fillinger, Mary P ^a   DiScipio, Anthony W ^a   Gloor, Kelly E ^a   Gregory, Janice A ^a   Guyre, Paul M ^a  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

Cardiac surgery; Glucocorticoid; Interleukin 10; Interleukin 6; Systemic inflammation

Indexed keywords

ETOMIDATE; HYDROCORTISONE; INTERLEUKIN 10; INTERLEUKIN 6;

ADULT; AGED; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CARDIOPULMONARY BYPASS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CYTOKINE PRODUCTION; DOUBLE BLIND PROCEDURE; ELECTIVE SURGERY; HEART SURGERY; HEART VALVE REPLACEMENT; HORMONE SYNTHESIS; HUMAN; HYDROCORTISONE BLOOD LEVEL; MAJOR CLINICAL STUDY; PATIENT SCHEDULING; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 22144488833     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CCM.0000164565.65986.98     Document Type: Article

References (31)

1. Hench PS, Kendall EC, Slocumb CH, et al: The effect of a hormone of the adrenal cortex (17-hydroxy-11-dehydrocorticosterone: Compound E) and of pituitary adrenocorticotropic hormone on rheumatoid arthritis: Preliminary report. Proceedings of the Staff Meetings of the Mayo Clinic 1949; 24:181-197
2. Laffey JG, Boylan JF, Cheng DCH: The systemic inflammatory response to cardiac surgery. Anesthesiology 2002; 97:215-252
3. Wan S, LeClerc J-L, Vincent J-L: Inflammatory response to cardiopulmonary bypass: Mechanisms involved and possible therapeutic strategies. Chest 1997; 112:676-692
4. Tabardel Y, Duchateau J, Schmartz D, et al: Corticosteroids increase blood interleukin-10 levels during cardiopulmonary bypass in men. Surgery 1996; 119:76-80
5. Sauerland S, Nagelschmidt M, Mallmann P, et al: Risks and benefits of preoperative high dose methylprednisolone in surgical patients: A systemic review. Drug Saf 2000; 23:449-461
6. Kraan GPB, Dullaart RPF, Pratt JJ, et al: The daily cortisol production reinvestigated in healthy men. The serum and urinary cortisol production rates are not significantly different. J Clin Endocrinol Metab 1998; 83:1247-1252
7. Barber AE, Coyle SM, Marano MA, et al: Glucocorticoid therapy alters hormonal and cytokine responses to endotoxin in man. J Immunol 1999; 150:1999-2006
8. Roth-Isigheit A, Brechmann J, Dibbelt L, et al: Persistent endocrine stress response in patients undergoing cardiac surgery. J Endocrinol Invest 1998; 21:12-19
9. Fillinger MP, Rassias AJ, Guyre PM, et al: Glucocorticoid effects on the inflammatory and clinical responses to cardiac surgery. J Cardiothorac Vasc Anesth 2002; 16:163-169
10. Wei M, Kuukasjärvi P, Laurikka J, et al: Inflammatory cytokines and soluble receptors after coronary artery bypass grafting. Cytokine 2001; 15:223-228
11. Taylor KM, Bain WH, Jones JV, et al: The effect of hemodilution on plasma levels of cortisol and free cortisol. J Thorac Cardiovasc Surg 1976; 72:57-61
12. Vogeser M, Felbinger TW, Kilger E, et al: Corticosteroid-binding globulin and free cortisol in the early postoperative period after cardiac surgery. Clin Biochem 1999; 32:213-216
13. Kehlet H, Binder C: Alterations in distribution volume and biological half-life of cortisol during major surgery. J Clin Endocrinol Metab 1973; 36:330-333
14. Roth-Isigheit AK, Dibbelt L, Schmucker P: Blood levels of corticosteroid-binding globulin, total cortisol and unbound cortisol in patients undergoing coronary artery bypass grafting surgery with cardiopulmonary bypass. Steroids 2000; 65:513-520
15. Hall RI, Stafford Smith M, Rocker G: The systemic inflammatory response to cardiopulmonary bypass: Pathophysiological, therapeutic, and pharmacological considerations. Anesth Analg 1997; 85:766-782
16. Oka Y, Murata A, Nishijima J, et al: Circulating interleukin 6 as a useful marker for predicting postoperative complications. Cytokine 1992; 4:298-304
17. Kilger E, Weis F, Briegel J, et al: Stress doses of hydrocortisone reduce severe systemic inflammatory response syndrome and improve early outcome in a risk group of patients after cardiac surgery. Crit Care Med 2003; 31:1068-1074
18. Kishimoto T, Akira S, Taga T: Interleukin-6 and its receptor: A paradigm for cytokines. Science 1992; 258:593-597
19. Bamberger CM, Schulte HM, Chrousos GP: Molecular determinants of glucocorticoid receptor function and tissue sensitivity to glucocorticoids. Endocr Rev 1996; 17:245-261
20. Goulding NJ: The molecular complexity of glucocorticoid actions in inflammation - A four-ring circus. Curr Opin Pharmacol 2004; 4:629-636
21. Donn RP, Ray DW: Macrophage migration inhibitory factor: Molecular, cellular and genetic aspects of a key neuroendocrine molecule. J Endocrinol 2004; 182:1-9
22. Fingerle-Rowson G, Koch P, Bikoff R, et al: Regulation of macrophage migration inhibitory factor expression by glucocorticoids in vivo. Am J Pathol 2003; 162:47-56
23. Gando S, Nishihira J, Kemmotsu O, et al: An increase in macrophage migration inhibitory factor release in patients with cardiopulmonary bypass surgery. Surg Today 2000; 30:689-694
24. Yeager MP, Guyre PM, Munck AU: Glucocorticoid regulation of the inflammatory response to injury. Acta Anaesthesiol Scand 2004; 48:799-813
25. Wan S, LeClerc J-L, Schmartz D, et al: Hepatic release of interleukin-10 during cardiopulmonary bypass in steroid-pretreated patients. Am Heart J 1997; 133:335-339
26. Dandona P, Aljada A, Garg R, et al: Increase in plasma interleukin-10 following hydrocortisone injection. J Clin Endocrinol Metab 1999; 84:1141-1144
27. Wiegers GJ, Reul JMHM: Induction of cytokine receptors by glucocorticoids: Functional and pathological significance. Trends Pharmacol Sci 1998; 19:317-321
28. Pajkrt D, Camoglio L, Tiel-van Buul MCM, et al: Attenuation of proinflammatory response by recombinant human IL-10 in human endotoxemia. J Immunol 1997; 158:3971-3977
29. Annane D, Sebille V, Charpentier C, et al: Effect of treatment with low dose hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 2002; 288:862-871
30. Keh D, Sprung CL: Use of corticosteroid therapy in patients with sepsis and septic shock: An evidence-based review. Crit Care Med 2004; 32:8527-8533
31. Annane D, Sebille V, Troche G, et al: A 3-level prognostic classification in septic shock based on cortisol levels and cortisol response to corticotropin. JAMA 2000; 283:1038-1045